PubMed:19782135 / 319-553 JSONTXT

{"project":"c_corpus","denotations":[{"id":"T47","span":{"begin":45,"end":54},"obj":"D004967"},{"id":"T48","span":{"begin":45,"end":54},"obj":"D004967"},{"id":"T49","span":{"begin":45,"end":54},"obj":"CHEBI:50114"},{"id":"T50","span":{"begin":111,"end":118},"obj":"D004194"},{"id":"T51","span":{"begin":111,"end":118},"obj":"D004194"},{"id":"T52","span":{"begin":157,"end":168},"obj":"D006965"},{"id":"T53","span":{"begin":157,"end":168},"obj":"D006965"},{"id":"T55","span":{"begin":172,"end":176},"obj":"CVCL_5552"},{"id":"T54","span":{"begin":172,"end":176},"obj":"D002285"},{"id":"T56","span":{"begin":172,"end":176},"obj":"D002285"},{"id":"T57","span":{"begin":214,"end":223},"obj":"D002277"},{"id":"T58","span":{"begin":214,"end":223},"obj":"D002277"},{"id":"T60","span":{"begin":229,"end":233},"obj":"CVCL_5552"},{"id":"T59","span":{"begin":229,"end":233},"obj":"D002285"},{"id":"T61","span":{"begin":229,"end":233},"obj":"D002285"}],"text":"In these intraductal proliferative diseases, estrogens are considered to be involved in the progression of the disease especially from ductal non-neoplastic hyperplasia to DCIS and possibly development of invasive carcinoma from DCIS."}

{"project":"UseCases_ArguminSci_Discourse","denotations":[{"id":"T3","span":{"begin":0,"end":234},"obj":"DRI_Challenge"}],"text":"In these intraductal proliferative diseases, estrogens are considered to be involved in the progression of the disease especially from ductal non-neoplastic hyperplasia to DCIS and possibly development of invasive carcinoma from DCIS."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T2","span":{"begin":0,"end":234},"obj":"DRI_Challenge"}],"text":"In these intraductal proliferative diseases, estrogens are considered to be involved in the progression of the disease especially from ductal non-neoplastic hyperplasia to DCIS and possibly development of invasive carcinoma from DCIS."}